4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-22-000065
SVP Corporate Development sold 2,186 shares at an average $424.68 ($928,359)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-15 | Sale | −1,016 | $412.41 | $419,009 | 7,804 | D |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-16 | Sale | −686 | $425.00 | $291,550 | 7,118 | D |
| Dolan Matthew Vincent SVP Corporate Development | 2022-03-17 | Sale | −484 | $450.00 | $217,800 | 6,634 | D |
| Open-market sales · 2,186 sh · avg $424.68 · $928,359 | |||||||
Loading xslF345X03/edgardoc.xml…